Summary of evidence
| Condition | Evidence level |
|---|---|
| *Not specifically discussed at one day authors' meeting. | |
| Guillain-Barré syndrome | 1a |
| Chronic inflammatory demyelinating polyneuropathy | 1b |
| Multifocal motor neuropathy | 1b |
| Other lower motor neuron syndromes | IV |
| Amyotrophic lateral sclerosis* | III against current use |
| Neuropathy associated with paraprotein | IV |
| Myasthenia gravis (acute severe or deteriorating) | 1b |
| Lambert-Eaton syndrome | 1b |
| Inclusion body myositis | 1b against current use |
| Dermatomyositis | 1b |
| Polymyositis | IV |
| Stiff-man syndrome | III/IV |
| Multiple sclerosis (relapse rate ?disability) | 1b |
| Kawasaki disease | 1a |
| Sarcoid, Behçet's disease | no evidence |
| CNS vasculitis | III/IV |
| CNS lupus, antiphospholipid syndromes | IV |
| Epilepsy | III/IV |
| Lennox Gastaut, West syndromes | III/IV |
| Rasmussen encephalitis | IV |
| Landau-Kleffner syndrome | IV |
| Paraneoplastic disorders of the CNS | III/IV |
| Adrenoleukodystrophy*158 | III against current use |